The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma

Histone deacetylase (HDAC) inhibitors, especially vorinostat, are currently under investigation as potential adjuncts in the treatment of neuroblastoma. The effect of vorinostat co-treatment on the development of resistance to other chemotherapeutic agents is unknown. In the present study, we treate...

Full description

Saved in:
Bibliographic Details
Main Authors: Lautz, Timothy B., Jie, Chunfa, Clark, Sandra, Naiditch, Jessica A., Jafari, Nadereh, Qiu, Yi-Yong, Zheng, Xin, Chu, Fei, Madonna, Mary Beth
Format: Artigo
Language:Inglês
Published: Public Library of Science 2012
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3400660/
https://ncbi.nlm.nih.gov/pubmed/22829886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0040816
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items